Esbriet
PHONETIC PRONUNCIATION: Esbriet
Description
Esbriet: An Overview of Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Esbriet (pirfenidone) is an oral medication that is used for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and life-threatening lung disease that causes the lung tissue to become scarred and stiff. The drug was approved by the U.S. Food and Drug Administration (FDA) in 2014 and is available in both branded and generic versions. Uses of Esbriet Esbriet is used to slow down the progression of IPF, which is a chronic and irreversible disease with no known cure. The medication reduces inflammation and scarring in the lungs and improves lung function, thereby improving the patient's quality of life and extending their survival. Dosage of Esbriet Esbriet is a tablet that is taken orally with meals. The recommended dosage is three capsules (or 801 mg) three times a day, for a total daily dose of 2,403 mg. The dosage may be adjusted depending on the patient's tolerability and response. The medication should be taken consistently at the same times each day. Demographic of Esbriet Esbriet is approved by the FDA for use in adults with IPF, which is most commonly diagnosed in individuals over age 50. It is effective in both male and female patients and those of different racial and ethnic backgrounds. Side Effects of Esbriet Esbriet may cause side effects in some patients. The most common side effects include nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, fatigue, and rash. These side effects are usually mild to moderate and go away on their own. Less common but more severe side effects may include liver problems, photosensitivity, allergic reactions, and blood disorders. Patients should be monitored for these side effects and report any unusual symptoms or changes in their health to their healthcare provider. Interactions with Esbriet Esbriet may interact with other medications, such as CYP1A2 inhibitors and inducers, which can affect how the drug is metabolized in the body. Patients should inform their healthcare provider about all the medications they are taking, including prescription and over-the-counter drugs, supplements, and herbal remedies. Generic Options for Esbriet Esbriet's patent expired in 2020, and several generic versions of the drug are now available. The generic versions are bioequivalent to the brand-name drug and are expected to be more affordable than the branded version. Conclusion Esbriet is an effective medication for the treatment of IPF, a chronic and debilitating lung disease. The drug reduces inflammation and scarring in the lungs, improves lung function, and extends the patient's survival. Esbriet is approved for use in adults and is available in both branded and generic versions. Like all medications, it may cause side effects and interact with other drugs, and patients should follow their healthcare provider's instructions carefully.
Faq for Esbriet
Esbriet (pirfenidone) is a prescription medication used to treat a lung disease called idiopathic pulmonary fibrosis (IPF).
The exact mechanism of action of Esbriet is not fully understood, but it is believed to reduce inflammation and fibrosis (scarring) in the lungs.
Esbriet is taken orally as a tablet. The usual recommended dosing is three capsules, three times a day with food.
The common side effects of Esbriet include nausea, diarrhea, abdominal pain, loss of appetite, rash, and fatigue.
Esbriet may start working within weeks, but it can take several months to see noticeable improvement in lung function.
Yes, Esbriet can be used along with other medications for idiopathic pulmonary fibrosis (IPF). However, it is important to consult your healthcare provider for specific recommendations.
Coverage for Esbriet varies depending on the insurance provider. It is recommended to check with your insurance company to determine coverage and potential out-of-pocket costs.
Esbriet is not recommended for use during pregnancy as it may harm the unborn baby. Effective contraception should be used by both males and females during treatment with Esbriet.
As of now, there is no generic version of Esbriet available. It is only available as a branded medication.
It is generally advisable to avoid or limit alcohol consumption while taking Esbriet, as alcohol may worsen certain side effects and potentially interfere with the efficacy of the medication.
The effects of Esbriet can vary from person to person. It may take several months of treatment to see improvements in lung function and symptom reduction. It is important to continue taking the medication as prescribed by your doctor.
If you miss a dose of Esbriet, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Esbriet is not recommended for use during pregnancy, as it may harm the unborn baby. It is also not known if the medication passes into breast milk, so it is recommended to consult with your doctor before using Esbriet while breastfeeding.
The duration of Esbriet treatment will be determined by your doctor based on your individual needs. In most cases, Esbriet is taken long-term to help manage the symptoms and slow down the progression of idiopathic pulmonary fibrosis.
Esbriet is not a cure for idiopathic pulmonary fibrosis (IPF), but it can help slow down the progression of the disease and improve lung function. The goal of treatment is to manage symptoms and improve quality of life.